Arrowhead Pharmaceuticals... (ARWR)
NASDAQ: ARWR
· Real-Time Price · USD
20.50
1.72 (9.16%)
At close: Aug 15, 2025, 3:59 PM
20.90
1.93%
After-hours: Aug 15, 2025, 07:44 PM EDT
Arrowhead Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Cash & Equivalents | 129.79M | 185.71M | 53.89M | 102.69M | 69.4M | 127.7M | 58.22M | 110.89M | 105.33M | 134.96M | 202.25M | 108M | 139.44M | 86.41M | 91.59M | 184.43M | 325.98M | 372.38M | 139.92M |
Short-Term Investments | 770.58M | 911.7M | 499.05M | 578.28M | 367.27M | 395.41M | 162.06M | 292.74M | 346.37M | 346.05M | 299.58M | 268.39M | 277.06M | 315.49M | 238.55M | 183.35M | 190.33M | 204.94M | 165.41M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 42.76M | 78.83M | 115.77M | 105.87M | 165.92M | 201.59M | 217.57M | 245.59M | 128.38M | 97.49M | 110.86M |
Other Long-Term Assets | 1.35M | 1.31M | 3.08M | 4.48M | 4.46M | 210K | 232K | 210K | 210K | 210K | 73.38M | 29.12M | 275K | 275K | 273K | 272K | 272K | 265K | 265K |
Receivables | 9.7M | 2.37M | 2.5M | n/a | n/a | n/a | n/a | n/a | 1.25M | 69.43M | 39.57M | 1.41M | 239K | 1.32M | 150K | 10.26M | 671K | 955K | 9M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.05M | n/a | -64.76M | -21.61M | 6.76M | 6.62M | 5.2M | 4.36M | 7.28M | 6.64M | 7.07M |
Other Current Assets | 36.85M | 11.68M | 5.74M | 4.97M | 4.18M | 7.51M | 7.1M | 7.08M | 7.16M | 14.44M | 25.19M | 20.2M | 8.89M | 7.8M | 2.79M | 2.19M | 1.7M | 1.84M | 2.32M |
Total Current Assets | 946.92M | 1.14B | 570.54M | 695.47M | 450.06M | 541.65M | 237.9M | 419.52M | 470.17M | 574.81M | 501.83M | 376.4M | 432.39M | 417.63M | 338.28M | 384.6M | 525.96M | 586.76M | 323.72M |
Property-Plant & Equipment | 425.05M | 429.25M | 431.94M | 431.29M | 420.25M | 403.88M | 378.32M | 335.56M | 272.04M | 226.34M | 188.97M | 168.59M | 140.81M | 71.27M | 69.18M | 66.02M | 66.24M | 57.77M | 49.48M |
Goodwill & Intangibles | 7.29M | 7.71M | 8.14M | 8.56M | 8.99M | 9.41M | 9.84M | 10.26M | 10.69M | 11.11M | 11.54M | 11.96M | 12.39M | 12.81M | 13.24M | 13.66M | 14.09M | 14.51M | 14.94M |
Total Long-Term Assets | 433.69M | 438.28M | 443.16M | 444.33M | 433.7M | 413.5M | 388.39M | 346.03M | 325.69M | 316.5M | 389.66M | 315.54M | 319.39M | 285.94M | 300.26M | 325.55M | 208.97M | 170.04M | 175.53M |
Total Assets | 1.38B | 1.57B | 1.01B | 1.14B | 883.76M | 955.15M | 626.29M | 765.55M | 795.86M | 891.31M | 891.49M | 691.94M | 751.78M | 703.58M | 638.54M | 710.15M | 734.93M | 756.79M | 499.25M |
Account Payables | 33.05M | 9.98M | 14.46M | 11.39M | 26.55M | 8.52M | 4.46M | 35.87M | 7.87M | 9.56M | 796K | 2.87M | 5.89M | 10.6M | 4.07M | 9.46M | 10.04M | 5.3M | 4.83M |
Deferred Revenue | 22.98M | 43.27M | n/a | n/a | n/a | n/a | n/a | 866K | 16.91M | 29.84M | 66.28M | 74.1M | 84.29M | 97.87M | 108.65M | 111.06M | 150.93M | 144.88M | 6.74M |
Short-Term Debt | 7.01M | 65M | 1.63M | n/a | n/a | 5.29M | 3.42M | 10.56M | 2.82M | n/a | 2.66M | 2.78M | 2.88M | 2.91M | 2.83M | 2.25M | 1.29M | 1.27M | 1.18M |
Other Current Liabilities | 112.19M | 448K | 440K | 432K | 48.32M | 32.34M | -2.96M | 29.64M | 35.37M | n/a | 91.02M | 88.16M | 59.23M | 41.6M | 31.38M | 23.5M | 56.47M | 11.61M | 8.4M |
Total Current Liabilities | 194.53M | 220.54M | 93.76M | 103.17M | 96.71M | 65.17M | 63.72M | 105.46M | 70.23M | 87.15M | 66.28M | 74.1M | 128.21M | 138.86M | 137.03M | 146.54M | 195.43M | 167.19M | 25.09M |
Long-Term Debt | 105.69M | 561.2M | 407.79M | 393.18M | 336.03M | 280.94M | 273.69M | 268.33M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 366.06M | n/a | 346.78M | 341.36M | n/a | 280.94M | n/a | n/a | 263.73M | 258.98M | 252.85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 471.75M | 668.73M | 863.86M | 845.57M | 448.07M | 394.57M | 388.85M | 372.93M | 343.64M | 339.05M | 428.84M | 511.88M | 149.39M | 112.45M | 128.95M | 154.79M | 102.6M | 144.06M | 19.68M |
Total Liabilities | 666.28M | 889.27M | 957.62M | 948.74M | 544.78M | 459.75M | 452.57M | 478.39M | 413.87M | 426.2M | 495.12M | 585.98M | 277.61M | 251.31M | 265.98M | 301.33M | 298.04M | 311.25M | 44.78M |
Total Debt | 112.7M | 388.24M | 525.27M | 510.55M | 454.12M | 399.86M | 392.27M | 383.5M | 82.73M | 82.78M | 82.13M | 81.58M | 81.11M | 25.61M | 25.32M | 25.55M | 24.14M | 23.8M | 20.87M |
Common Stock | 230K | 230K | 218K | 217K | 217K | 217K | 200K | 200K | 199K | 199K | 106.14M | 105.96M | 198K | 198K | 197K | 197K | 197K | 196K | 195K |
Retained Earnings | -1.6B | -1.43B | -1.8B | -1.63B | -1.45B | -1.28B | -1.16B | -1.03B | -916.35M | -813.4M | -862.08M | -820.75M | -735.24M | -663.2M | -707.56M | -644.69M | -581.32M | -551.39M | -524.58M |
Comprehensive Income | 5.36M | 4.39M | 4.14M | 4.75M | -987K | -1.09M | -1.25M | -3.22M | -411K | -332K | -258K | -136K | -140K | -107K | -108K | -69K | 62K | 102K | 198K |
Shareholders Equity | 519.81M | 683.32M | 52.59M | 185.44M | 330.55M | 483.79M | 160.41M | 271.34M | 364.83M | 446.77M | 377.04M | 105.96M | 453.93M | 452.27M | 372.56M | 408.82M | 436.89M | 445.55M | 454.47M |
Total Investments | 770.58M | 911.7M | 499.05M | 578.28M | 367.27M | 395.41M | 162.06M | 292.74M | 389.13M | 424.88M | 415.36M | 374.26M | 442.98M | 517.08M | 456.12M | 428.95M | 318.71M | 302.43M | 276.26M |